Susan M Lopata1,2, Elizabeth McNeer3,4, Judith A Dudley5, Carolyn Wester6, William O Cooper7,3,5, James G Carlucci7,8, Claudia M Espinosa9,10, William Dupont4,5, Stephen W Patrick7,2,3,5. 1. Departments of Pediatrics, susan.m.lopata@vumc.org. 2. Divisions of Neonatology and. 3. Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. 4. Biostatistics, and. 5. Health Policy, and. 6. Tennessee Department of Health, Nashville, Tennessee; and. 7. Departments of Pediatrics. 8. Pediatric Infectious Diseases. 9. Department of Pediatrics, School of Medicine, University of Louisville, Louisville, Kentucky. 10. Division of Pediatric Infectious Diseases and.
Abstract
BACKGROUND: Hepatitis C virus (HCV) prevalence doubled among pregnant women from 2009 to 2014, reaching 3.4 per 1000 births nationwide. Infants exposed to HCV may acquire HCV by vertical transmission. National guidelines recommend that infants exposed to HCV be tested; however, it is unclear if these recommendations are being followed. Our objectives were to determine if infants exposed to HCV were tested and to determine hospital- and patient-level factors associated with differences in testing. METHODS: In this retrospective cohort study of infants exposed to HCV who were enrolled in the Tennessee Medicaid program, we used vital statistics-linked administrative data for infants born between January 1, 2005, and December 31, 2014. Infants were followed until 2 years old. Multilevel logistic regression was used to assess the association of HCV testing and hospital- and patient-level characteristics. RESULTS: Only 23% of 4072 infants exposed to HCV were tested. Infants whose mothers were white versus African American (96.6% vs 3.1%; P <.001), used tobacco (78% vs 70%; P <.001), and had HIV (1.3% vs 0.4%; P = .002) were more likely to be tested. Infants exposed to HCV who had a higher median of well-child visits (7 vs 6; P <.001) were more likely to be tested. After accounting for maternal and infant characteristics and health care use patterns, African American infants were less likely to undergo general testing (adjusted odds ratio 0.32; 95% confidence interval, 0.13-0.78). CONCLUSIONS: Testing occurred in <1 in 4 infants exposed to HCV and less frequently among African American infants. Public health systems need to be bolstered to ensure that infants exposed to HCV are tested for seroconversion.
BACKGROUND:Hepatitis C virus (HCV) prevalence doubled among pregnant women from 2009 to 2014, reaching 3.4 per 1000 births nationwide. Infants exposed to HCV may acquire HCV by vertical transmission. National guidelines recommend that infants exposed to HCV be tested; however, it is unclear if these recommendations are being followed. Our objectives were to determine if infants exposed to HCV were tested and to determine hospital- and patient-level factors associated with differences in testing. METHODS: In this retrospective cohort study of infants exposed to HCV who were enrolled in the Tennessee Medicaid program, we used vital statistics-linked administrative data for infants born between January 1, 2005, and December 31, 2014. Infants were followed until 2 years old. Multilevel logistic regression was used to assess the association of HCV testing and hospital- and patient-level characteristics. RESULTS: Only 23% of 4072 infants exposed to HCV were tested. Infants whose mothers were white versus African American (96.6% vs 3.1%; P <.001), used tobacco (78% vs 70%; P <.001), and had HIV (1.3% vs 0.4%; P = .002) were more likely to be tested. Infants exposed to HCV who had a higher median of well-child visits (7 vs 6; P <.001) were more likely to be tested. After accounting for maternal and infant characteristics and health care use patterns, African American infants were less likely to undergo general testing (adjusted odds ratio 0.32; 95% confidence interval, 0.13-0.78). CONCLUSIONS: Testing occurred in <1 in 4 infants exposed to HCV and less frequently among African American infants. Public health systems need to be bolstered to ensure that infants exposed to HCV are tested for seroconversion.
Authors: Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg Journal: Clin Infect Dis Date: 2014-08-11 Impact factor: 9.079
Authors: Cara L Mack; Regino P Gonzalez-Peralta; Nitika Gupta; Daniel Leung; Michael R Narkewicz; Eve A Roberts; Philip Rosenthal; Kathleen B Schwarz Journal: J Pediatr Gastroenterol Nutr Date: 2012-06 Impact factor: 2.839
Authors: Faouzi I Maalouf; William O Cooper; James C Slaughter; Judith Dudley; Stephen W Patrick Journal: J Pediatr Date: 2018-05-10 Impact factor: 4.406
Authors: Rachel L Epstein; Vishakha Sabharwal; Elisha M Wachman; Kelley A Saia; Claudia Vellozzi; Susan Hariri; Benjamin P Linas Journal: J Pediatr Date: 2018-08-28 Impact factor: 6.314
Authors: Stephen W Patrick; William D Dupont; Elizabeth McNeer; Melissa McPheeters; William O Cooper; David M Aronoff; Sarah Osmundson; Bradley D Stein Journal: JAMA Health Forum Date: 2021-10-29